The Phar­ma­ceu­ti­cal So­ci­ety of Trinidad and To­ba­go (TSPTT) has wel­comed the ad­di­tion of five new drugs to the Chron­ic Dis­ease As­sis­tance Pro­gramme (CDAP) but hopes to meet with Health Min­is­ter Dr Lack­ram Bo­doe to dis­cuss fur­ther im­prove­ments to the na­tion­al ini­tia­tive.

TSPTT past pres­i­dent Allyson Pouchet said the so­ci­ety was pleased with the new ad­di­tions, which she be­lieves will en­hance med­ical out­comes for pa­tients na­tion­wide. She told Guardian Me­dia that the as­so­ci­a­tion is await­ing an ap­point­ment with the min­is­ter.

The re­vised CDAP list took ef­fect on Oc­to­ber 1, fol­low­ing a com­pre­hen­sive re­view of the pro­gramme’s clin­i­cal, op­er­a­tional, and fi­nan­cial per­for­mance by the CDAP Re­view Com­mit­tee on June 5. The com­mit­tee’s rec­om­men­da­tions in­clud­ed up­dat­ing the drug list to re­flect mod­ern treat­ment stan­dards, strength­en­ing di­ag­nos­tic sup­port, and ex­pand­ing ac­cess in rur­al and un­der­served com­mu­ni­ties.